SCHEMBL31722116

SCHEMBL31722116

Fc1cccc(F)c1-c1cccc2cn[nH]c12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NOS1 P29475 3/20 0.50
▸ TRPA1 O75762 4/20 0.44
▸ PLK4 O00444 1/20 0.44
▸ CHEK1 O14757 1/20 0.44
▸ AURKA O14965 1/20 0.44
▸ DAPK3 O43293 1/20 0.44
▸ MAP4K4 O95819 1/20 0.44
▸ CSF1R P07333 1/20 0.44
▸ RET P07949 1/20 0.44
▸ FGFR1 P11362 1/20 0.44
▸ PDGFRA P16234 1/20 0.44
▸ LTK P29376 1/20 0.44
▸ KDR P35968 1/20 0.44
▸ MAP2K2 P36507 1/20 0.44
▸ FLT3 P36888 1/20 0.44
▸ CSNK1A1 P48729 1/20 0.44
▸ PRKX P51817 1/20 0.44
▸ CDK5 Q00535 1/20 0.44
▸ MAP2K1 Q02750 1/20 0.44
▸ MST1R Q04912 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3519434 0.83 NOS1 (0.59) NOS1TRPA1PLK4CHEK1AURKA
SCHEMBL3064844 0.82 NOS1 (0.63) NOS1TRPA1PLK4CHEK1AURKA
SCHEMBL4752843 0.74 NOS1 (0.53) NOS1PLK4CHEK1AURKADAPK3
SCHEMBL31539809 0.70 NOS1 (0.48) NOS1TRPA1PLK4CHEK1AURKA
SCHEMBL5020194 0.70 NOS1 (0.49) NOS1TRPA1PLK4CHEK1AURKA
SCHEMBL30741485 0.69 NOS1 (0.47) NOS1PLK4CHEK1AURKADAPK3
SCHEMBL14231151 0.69 NOS1 (0.61) NOS1PLK4CHEK1AURKADAPK3
SCHEMBL19920463 0.68 RPS6KA2 (0.47) NOS1TRPA1RETFGFR1KDM4E
SCHEMBL23198253 0.68 NOS1 (0.46) NOS1PLK4CHEK1AURKADAPK3
SCHEMBL20997887 0.68 NOS1 (0.46) NOS1TRPA1PLK4CHEK1AURKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025229494-A1 HETEROCYCLIC COMPOUND TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2025-11-06 — — WO disclosed
Send feedback